D'Silva Andrew J.insider trades
In SEC Form 4 filings, D'Silva Andrew J. is listed as Chief Business Officer of OptimizeRx Corp (OPRX). D'Silva Andrew J. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 2.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| OPRXOptimizeRx Corp | Chief Business Officer | 4 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-24
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| OPRXOptimizeRx Corp | Oct 1 | Oct 2 | F | 414 | $8.39 | $3,473 | 99,246 | No | Form 4 |
| OPRXOptimizeRx Corp | Sep 1 | Sep 2 | F | 1,432 | $7.86 | $11,256 | 99,660 | No | Form 4 |
| OPRXOptimizeRx Corp | Aug 21 | Aug 24 | F | 1,243 | $7.71 | $9,584 | 43,492 | No | Form 4 |
| OPRXOptimizeRx Corp | Aug 20 | Aug 24 | A | 57,600 | $0.00 | $0 | 101,092 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.